CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 75 enrolled
Drug / intervention
Unstuck and on Targetbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04295512
NCT04295512N/ACompleted

Adaptation and Implementation of an ASD Executive Functioning Intervention in Children's Mental Health Services

San Diego State University·interventional·Posted Mar 4, 2020·Updated Feb 27, 2025

In Brief

A clinical study evaluating Unstuck and on Target for Autism Spectrum Disorder and 2 related conditions. Completed, enrolled 75 participants across 1 site.

Detailed Summary

The purpose of this project is to conduct a feasibility test of an ASD executive functioning intervention adapted for mental health settings, including examining the effectiveness and process of implementing this adapted intervention in community mental health programs.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedMar 4, 2020
Enrollment StartJul 15, 2021
Primary CompletionMay 20, 2023
Study CompletionMay 31, 2023
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 6.3 years ago

Interventions

Unstuck and on Targetbehavioral

Unstuck and on Target is a cognitive-behavioral treatment that directly addresses executive functioning and self-regulation deficits in ASD and ADHD. Unstuck and on Target is the first contextually-based executive functioning treatment that targets flexibility, goal-setting and planning through a cognitive behavioral program centered on self-regulatory scripts that are consistently modeled and reinforced. Unstuck and on Target will be adapted for use in mental health service settings. Mental health therapists will be trained in Unstuck and on Target and deliver to youth and caregivers.